Replies to post #5791 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

The description of the US Atryn trial may be found at:

http://clinicaltrials.gov/ct2/show/NCT00110513

This web page was last updated in Aug, which is the reason it shows enrollment still being open.

Compared to the older description of the trial in #msg-6632420, the only change of consequence is that patients with two hereditary deficiencies previously excluded (Factor V Leiden and prothrombin gene mutation) were allowed in. This change was made in 2006 to facilitate enrollment.